| Autor: |
Nongonierma AB; Department of Biological Sciences and Food for Health Ireland (FHI), University of Limerick, Limerick, Ireland., Dellafiora L; Food and Drug Department, University of Parma, Parma, Italy., Paolella S; Department of Biological Sciences and Food for Health Ireland (FHI), University of Limerick, Limerick, Ireland., Galaverna G; Food and Drug Department, University of Parma, Parma, Italy., Cozzini P; Food and Drug Department, University of Parma, Parma, Italy., FitzGerald RJ; Department of Biological Sciences and Food for Health Ireland (FHI), University of Limerick, Limerick, Ireland. |
| Abstrakt: |
Inhibition of dipeptidyl peptidase IV (DPP-IV) may be exploited to maintain the incretin effect during the postprandial phase. As a result, glycemic regulation and energy homeostasis may be improved. Food protein-derived peptides have been identified as natural agents capable of inhibiting DPP-IV. Ile-Pro-Ile is the most potent DPP-IV inhibitory peptide identified to date. A minimum analog peptide set approach was used to study peptide analogs of Ile-Pro-Ile. The DPP-IV half maximal inhibitory concentration (IC 50 ) values of the 25 peptides evaluated ranged from 3.9 ± 1.0 µM (Ile-Pro-Ile) to 247.0 ± 32.7 µM (Phe-Pro-Phe). The presence of Pro at position 2 of tripeptides was required to achieve high DPP-IV inhibition. Most peptides behaved as competitive inhibitors of DPP-IV with the exception of peptides with a N-terminal Trp, which were mixed-type inhibitors. While possessing the structure of preferred DPP-IV substrates, most peptides studied were particularly stable during 30 min incubation with DPP-IV. Molecular docking revealed that Ile-Pro-Ile and its peptide analogs interacted in a very similar manner with the active site of DPP-IV. In addition, no correlation was found between the Hydropathic INTeraction score and the DPP-IV IC 50 values of the peptides studied. This outcome suggests that free energy may not be directly responsible for enzyme inhibition by the peptides. Finally, novel DPP-IV inhibitory peptides were identified using the strategy employed herein. These results may be relevant for the development of food protein-derived peptides with serum glucose lowering and food intake regulatory properties in humans. |
